A novel endogenous CD16-Expressing Natural Killer Cell for cancer immunotherapy

por Cheng, Zih-Fei, Li, Hao-Kang, Yang, Hsiu-Ping, Lee, Chia-Yun, Tang, Sai-Wen, Lin, Yan-Liang, Hsiao, Shih-Chia
Publicado 2021

A Novel off-the-Shelf Trastuzumab-Armed NK Cell Therapy (ACE1702) Using Antibody-Cell-Conjugation Technology

por Li, Hao-Kang, Hsiao, Ching-Wen, Yang, Sen-Han, Yang, Hsiu-Ping, Wu, Tai-Sheng, Lee, Chia-Yun, Lin, Yan-Liang, Pan, Janet, Cheng, Zih-Fei, Lai, Yan-Da, Hsiao, Shih-Chia, Tang, Sai-Wen
Publicado 2021

Sorafenib analogue SC‐60 induces apoptosis through the SHP‐1/STAT3 pathway and enhances docetaxel cytotoxicity in triple‐negative breast cancer cells

por Liu, Chun‐Yu, Su, Jung‐Chen, Huang, Tzu‐Ting, Chu, Pei‐Yi, Huang, Chun‐Teng, Wang, Wan‐Lun, Lee, Chia‐Han, Lau, Ka‐Yi, Tsai, Wen‐Chun, Yang, Hsiu‐Ping, Shiau, Chung‐Wai, Tseng, Ling‐Ming, Chen, Kuen‐Feng
Publicado 2017

Varlitinib Downregulates HER/ERK Signaling and Induces Apoptosis in Triple Negative Breast Cancer Cells

por Liu, Chun-Yu, Chu, Pei-Yi, Huang, Chun-Teng, Chen, Ji-Lin, Yang, Hsiu-Ping, Wang, Wan-Lun, Lau, Ka-Yi, Lee, Chia-Han, Lan, Tien-Yun, Huang, Tzu-Ting, Lin, Po-Han, Dai, Ming-Shen, Tseng, Ling-Ming
Publicado 2019

A Novel Allogeneic Rituximab-Conjugated Gamma Delta T Cell Therapy for the Treatment of Relapsed/Refractory B-Cell Lymphoma

por Li, Hao-Kang, Wu, Tai-Sheng, Kuo, Yi-Chiu, Hsiao, Ching-Wen, Yang, Hsiu-Ping, Lee, Chia-Yun, Leng, Pei-Ju, Chiang, Yun-Jung, Cheng, Zih-Fei, Yang, Sen-Han, Lin, Yan-Liang, Chen, Li-Yu, Chen, Ciao-Syuan, Chen, Yu-Ju, Hsiao, Shih-Chia, Tang, Sai-Wen
Publicado 2023